Vaccines

19 Feb 2010 NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
18 Feb 2010 VIRxSYS Announces at CROI Promising Results from Its HIV Vaccine Study
18 Feb 2010 GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
17 Feb 2010 Immune Targeting Systems (ITS) Ltd. Secures an GBP 8.65 mln Series A Extension to Fund FP-01, Its Synthetic Universal Flu Vaccine Through Phase-II Studies
17 Feb 2010 In Phase III Data Merck's GARDASIL® Was Efficacious Against Anal Disease Caused by HPV 6,11,16, and 18
12 Feb 2010 Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
11 Feb 2010 Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae
10 Feb 2010 Cancer Research UK to Fund Clinical Trial of ADXS11-001 for the Treatment of Head and Neck Cancer
08 Feb 2010 NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
08 Feb 2010 Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate
08 Feb 2010 Nabi Biopharmaceuticals Completes Another PentaStaph(TM) Milestone
08 Feb 2010 Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
08 Feb 2010 Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)
02 Feb 2010 Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
01 Feb 2010 FIRST TREATMENT TO IMPROVE SURVIVAL IN 20 YEARS NOW AVAILABLE FOR PATIENTS WITH OSTEOSARCOMA (BONE CANCER)
31 Jan 2010 Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines
28 Jan 2010 Vical Completes Enrollment in Allovectin-7(r) Phase 3 Trial for Metastatic Melanoma
20 Jan 2010 New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
19 Jan 2010 Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite and Cat Allergies
19 Jan 2010 Mymetics Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
15 Jan 2010 International Medica Foundation Reaches Final Vaccination Milestone in Phase II Clinical Trial for Rotavirus Vaccine
13 Jan 2010 Start of Phase II Study for Intranasal, Seasonal Influenza Vaccine deltaFLU AVIR Green Hills Biotechnology AG
13 Jan 2010 Xcellerex Initiates Phase I Clinical Trial of Novel Yellow Fever Vaccine
12 Jan 2010 NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
11 Jan 2010 Inhibitex Provides Update on Its Staph Vaccine, FV-100 and INX-189 Development Programs

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top